Melissa Parsons
Family · Asheboro, NCNPI 1437622875
Payments from drug & device makers
Across 118 payments — averaging $19.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$267
- Seagen Inc.$198
- Incyte Corporation$169
- E.r. Squibb & Sons, L.L.C.$147
- Pfizer$140
- Amgen$127
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,13292%
- Education$1948%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 9 | $267 |
| Seagen Inc. | 8 | $198 |
| Incyte Corporation | 5 | $169 |
| E.r. Squibb & Sons, L.L.C. | 9 | $147 |
| Pfizer | 9 | $140 |
| Amgen | 8 | $127 |
| Pharmacosmos Therapeutics Inc. | 1 | $114 |
| Johnson & Johnson | 7 | $106 |
| Eisai Inc. | 5 | $89 |
| Merck | 4 | $69 |
| Daiichi Sankyo Inc. | 3 | $68 |
| Bristol Myers Squibb | 4 | $68 |
| Jazz Pharmaceuticals Inc. | 4 | $59 |
| Exelixis Inc. | 4 | $59 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Puma Biotechnology, Inc. | 3 | $45 |
| EMD Serono, Inc. | 3 | $43 |
| Tersera Therapeutics LLC | 2 | $42 |
| Beone Medicines USA, Inc. | 2 | $42 |
| Sanofi | 2 | $38 |
| GSK | 2 | $34 |
| Dova Pharmaceuticals | 2 | $30 |
| Boehringer Ingelheim | 2 | $29 |
| AbbVie | 2 | $27 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Array Biopharma Inc | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Deciphera Pharmaceuticals Inc. | 1 | $18 |
| Servier Pharmaceuticals LLC | 1 | $18 |
| Taiho Oncology, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Gilead | 1 | $15 |
| Bayer | 1 | $15 |
| ADC Therapeutics America, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,326 in reported general payments places this provider in the 85th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Exemestane | 12 | $910 |
Paid to pharmacies, not to this prescriber.
Other family in Asheboro
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
- Debra ScottCharlotte$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.